An ALLG single arm phase II study to evaluate the efficacy of asciminib in newly diagnosed patients with chronic phase chronic myeloid leukaemia (ASCEND-CML)

Project: Research

Project Details

StatusActive
Effective start/end date23/02/21 → 22/02/26

Keywords

  • phase 2 study
  • treatment safety
  • treatment efficacy
  • myeloid leukemia

Clinical Trial Phase

  • Phase II